Avigen Inc \De - Current report filing
October 24 2007 - 11:46AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC
20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
October 24, 2007
AVIGEN, INC.
(Exact name of registrant as specified in charter)
Delaware
|
000-28272
|
13-3647113
|
(State or other
jurisdiction of
|
(Commission File
Number)
|
(I.R.S. Employer
Identification
|
incorporation)
|
|
No.)
|
1301 Harbor Bay Parkway
Alameda,
California 94502
(Address of principal
executive offices and zip code)
Registrants telephone number, including
area code:
(510) 748-7150
_______________________________
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and
Financial Condition.
On
October 24, 2007, Avigen, Inc. issued a press release announcing its third
quarter 2007 financial results. A copy of the press release is attached as
Exhibit 99.1 to this current report and is incorporated herein by
reference.
The information in this Section 2.02
and in the press release attached as Exhibit 99.1 to this current report, shall
not be deemed to be filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as
amended. The information contained in this Section 2.02 and in the accompanying
exhibit shall not be incorporated by reference into any filing with the U.S.
Securities and Exchange Commission made by Avigen, Inc., whether made before or
after the date hereof, regardless of any general incorporation language in such
filing.
Item 9.01 Financial Statements and
Exhibits.
|
Exhibit
|
|
|
Number
|
Description
|
|
99.1
|
Press Release,
dated October
24,
2007,
announcing
Avigens
third
quarter
2007 financial results.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
A
VIGEN
, I
NC
.
|
|
|
Dated:
|
October 24,
2007
|
By:
|
/s/ Andrew Sauter
|
|
|
|
Andrew Sauter
|
|
|
|
Vice President,
Finance
|
INDEX
TO
EXHIBITS
|
Exhibit
|
|
|
Number
|
Description
|
|
99.1
|
Press Release,
dated October
24,
2007,
announcing
Avigens
third
quarter
2007 financial
results.
|
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Aug 2023 to Aug 2024